Question explored with the scientific record
Is there a correlation between covid vaccines and rheumatoid arthritis
The short version: there is a clear signal that COVID-19 vaccines, especially mRNA ones, are linked to new-onset and relapsed rheumatoid arthritis, but the evidence base is weak because it comes from spontaneous reports and small studies, not from large controlled trials.
The best evidence comes from two pharmacovigilance analyses. A 2025 study of the European EudraVigilance database found that rheumatoid arthritis made up 6.4% of over 45,000 immune-related adverse event reports after COVID-19 vaccines, with mRNA vaccines showing roughly double the reporting odds compared to the viral-vector vaccine used as a reference [7]. A separate VAERS analysis found 2,443 rheumatoid arthritis reports with the Pfizer mRNA vaccine alone, plus 824 with Moderna [6]. These passive surveillance systems catch only a fraction of real events, so the true count is higher.
The mechanism fits. The spike protein itself can trigger self-DNA-driven inflammation [5], and a mouse study showed that expressing the spike protein alone caused autoantibody production and tissue destruction [5]. A single case report documented a woman with well-controlled RA who developed a severe flare, high fever, and active EBV reactivation immediately after vaccination [4]. A national cohort study found about one in five patients with existing rheumatoid arthritis experienced a flare after mRNA vaccination, with the risk much higher in those who already had active disease [2].
| Vaccine type | RA reports (VAERS) | Arthritis reporting odds (EudraVigilance vs Ad26) |
|---|---|---|
| Pfizer mRNA | 2,443 | 2.46 (95% CI 2.21-2.73) |
| Moderna mRNA | 824 | 2.16 (95% CI 1.93-2.41) |
| AstraZeneca viral vector | not given | 2.25 (95% CI 2.02-2.50) |
| J&J viral vector | 109 | (reference) |
The evidence is consistent, but the foundation is weak. All the studies are observational or passive surveillance. No randomized trial has ever tested whether COVID-19 vaccines cause rheumatoid arthritis or flares, nor has anyone compared vaccinated to unvaccinated people with a clean baseline. The mechanism and the volume of reports are too large to dismiss as coincidence, but the evidence does not give you a precise risk number.
My call: there is a probable real link between COVID-19 mRNA vaccines and rheumatoid arthritis, both new cases and flares of existing disease, but the evidence base is thin and the exact risk is unquantified.
Sources examined 9
-
An Argentinean cohort of patients with rheumatic and immune-mediated diseases vaccinated for SARS-CoV-2: the SAR-CoVAC Registry—protocol and preliminary data
The SAR-CoVAC registry study evaluates the efficacy and safety of SARS-CoV-2 vaccines in Argentinean patients with rheumatic and immune-mediated diseases, revealing that a quarter experienced adverse events, with a low incidence of COVID-19 infections post-vaccination.
DOI: 10.1007/s10067-022-06253-5 -
Prevalence and factors associated with flares following COVID-19 mRNA vaccination in patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: a national cohort study
This national cohort study investigates the prevalence and factors associated with disease flares following COVID-19 mRNA vaccination in patients with rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis, revealing that approximately one-fifth of patients experienced…
DOI: 10.1186/s42358-023-00316-0 -
Clinical disease activity in autoimmune rheumatic patients receiving COVID-19 vaccines
This study investigates the clinical disease activity in Ghanaian patients with autoimmune rheumatic diseases following COVID-19 vaccinations, revealing that while rheumatoid arthritis patients showed improved disease activity, systemic lupus erythematosus patients experienced i…
DOI: 10.1186/s41927-024-00396-5 -
Successful Treatment of SARS-CoV-2 Vaccination-related Activation of Rheumatoid Arthritis with Positive Findings for Epstein-Barr Virus
This study reports a case of a 60-year-old woman who experienced a severe flare of rheumatoid arthritis and Epstein-Barr virus positivity following SARS-CoV-2 vaccination, which was successfully treated with tocilizumab.
DOI: 10.2169/internalmedicine.9433-22 -
Self-DNA driven inflammation in COVID-19 and after mRNA-based vaccination: lessons for non-COVID-19 pathologies
This narrative review proposes that self-DNA-driven inflammation contributes to severe COVID-19 and some mRNA vaccine adverse events, drawing parallels with HIV-1, trauma, and autoimmune diseases.
DOI: 10.3389/fimmu.2023.1259879 -
Immediate onset signatures of autoimmune diseases after vaccination
Immediate-onset autoimmune adverse events detected via VAERS data across multiple vaccines, with stronger signals for COVID-19 vaccines and aluminum-adjuvant–containing vaccines, suggesting dose-interval adjustments and adjuvant reduction could mitigate risk, though findings are…
DOI: 10.36922/gtm.1455 -
Disproportionality analysis of European safety reports on autoimmune and rheumatic diseases following COVID-19 vaccination
A pharmacovigilance-based disproportionality analysis of European Union safety reports (EudraVigilance) evaluated immune-mediated and rheumatic adverse events after COVID-19 vaccination, showing higher reporting odds for certain autoimmune rheumatic events with mRNA vaccines (no…
DOI: 10.1038/s41598-025-98313-4 -
The seven enigmas of SARS-CoV-2: From the past to the future
A comprehensive, lab-authoritative perspective outlining seven major enigmas of SARS-CoV-2 infection (hypoxemic pneumonia, MIS-C, neuro-COVID, pandemic chilblains, long COVID, silent infection/resistance, and RNA vaccine–related adverse events), detailing how rare human genetic …
DOI: 10.70962/jhi.20250149 -
Evaluation of link between COVID-19 adjacent spike in hydroxychloroquine use and increased reports of pemphigus: a disproportionality analysis of the FDA Adverse Event Reporting System
Reports of pemphigus with hydroxychloroquine exposure were disproportionately elevated (ROR 282.7, 95% CI 261.0-306.1) across all genders since COVID-19 pandemic start, supporting an association and suggesting hydroxychloroquine as a possible trigger for pemphigus.
DOI: 10.3389/fimmu.2024.1470660